← back to search

Hariharan Easwaran

GTx (United States) · US
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Cancer-related gene regulation, and RNA modifications and cancer.
h-index
33
citations
7,084
works
297
NIH funding
primary concept
Biology
email

Recent publications

Oncogenic Transformation Drives DNA Methylation Loss and Transcriptional Activation at Transposable Element Loci
Cancer Research 2023cited by 27position: middledoi
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Cell 2021cited by 584position: middledoi
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Nature 2020cited by 335position: middledoi
Aging-like Spontaneous Epigenetic Silencing Facilitates Wnt Activation, Stemness, and BrafV600E-Induced Tumorigenesis
Cancer Cell 2019cited by 190position: lastdoi
Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties
Cancer Cell 2019cited by 168position: middledoi
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Cancer Cell 2018cited by 122position: lastdoi
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
Cell Reports 2018cited by 100position: middledoi
Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations
Cancer Cell 2017cited by 194position: middledoi
Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress
Molecular Cell 2017cited by 145position: middledoi
Epigenetic regulation of gene expression in cancer: techniques, resources and analysis
Briefings in Functional Genomics 2017cited by 136position: middledoi
Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance
Molecular Cell 2014cited by 929position: firstdoi
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
Oncotarget 2014cited by 439position: middledoi
Prognostic value of CpG island methylator phenotype among colorectal cancer patients: a systematic review and meta-analysis
Annals of Oncology 2014cited by 164position: middledoi
Harnessing the potential of epigenetic therapy to target solid tumors
Journal of Clinical Investigation 2014cited by 155position: middledoi
Alterations of immune response of non-small cell lung cancer with Azacytidine
Oncotarget 2013cited by 388position: middledoi
DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes
Nucleic Acids Research 2012cited by 122position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stephen B. Baylin · Evangelisches Diakoniekrankenhaus10 papers (2012–2023) · 4 papers (2017–2023)Cynthia A. Zahnow · Johns Hopkins University4 papers (2014–2019)Ray-Whay Chiu Yen · Johns Hopkins University4 papers (2014–2019)Limin Xia · Chinese Academy of Medical Sciences & Peking Union Medical College3 papers (2017–2019)Yi Cai · Nanjing Agricultural University3 papers (2012–2019)Nita Ahuja · Johns Hopkins University3 papers (2014–2018)Ioannis Kagiampakis · Center for Cancer Research3 papers (2017–2018)Katherine B. Chiappinelli · George Washington University2 papers (2014–2023)Lauren Murphy · Women & Infants Hospital of Rhode Island2 papers (2017–2018)Michael J. Topper · Johns Hopkins University2 papers (2014–2019)Xiangqian Kong · Shandong University2 papers (2018–2019)Victor E. Velculescu · Sidney Kimmel Cancer Center2 papers (2017–2018)Dennis J. Slamon · APLA Health2 papers (2014–2018)Yong Tao · First Affiliated Hospital of Wannan Medical College2 papers (2018–2019)Jianjun Luo · South China Agricultural University2 papers (2014–2017) · 2 papers (2017–2018)Melissa Hadley · George Washington University1 papers (2023–2023)James I. McDonald · George Washington University1 papers (2023–2023)Doreen N. Palsgrove · Southwestern Medical Center1 papers (2018–2018)